Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

The Clinical Relevance of Residual, Persistent and Elongated Abnormal Sized Nodes By Longest Diameter (LDi) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL), Otherwise in a Complete Remission (CR)

Jayant Narang, MD, Surabhi Bajpai, MD, Rudresh Rajnikant Jarecha, MBBS,MD, Christiana Caplan, BS, Dana Macdonald, Gabriele Padrella, Manish Sharma, MD, Bruce D. Cheson, MD

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-136731

Published: 2020

Journal Articles

Mantle Cell Lymphoma: Incidence of Gastrointestinal Involvement and Correlation with Overall Response- Retrospective Review of Multiple Multicenter Trials

Surabhi Bajpai, MD, Jayant Narang, MD, Shweta Narang, MD, Ravikanth Mankala, MSc, BSc, Rudresh Rajnikant Jarecha, MBBS,MD, Manish Sharma, MD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-137657

Published: 2020

Journal Articles

REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-139192

Published: 2020

Journal Articles

Comparison of CT and PET-Based Assessments per Lugano Criteria in FDG-Avid Lymphoma- a Retrospective Analysis of Independent Review Assessments

Jayant Narang, MD, Surabhi Bajpai, MD, Rudresh Rajnikant Jarecha, MBBS, MD, Sayali Karve, PhD, Katarina Ludajic, PhD, Manish Sharma, MD, Shweta Narang, MD, Michael O'Connor, PhD

Blood (2019) 134 (Supplement_1): 5277.

https://doi.org/10.1182/blood-2019-130570

Published: 2019

Journal Articles

Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Dennis Cooper, MD, Deepu Madduri, MD, Suzanne Lentzsch, MD PhD, Sundar Jagannath, Jingjin Li, PhD, Anita Boyapati, PhD, Lieve Adriaens, PharmD, Dhruti Chokshi, BS, Min Zhu, PhD, Israel Lowy, MD PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Manish Sharma, MD, Maria Karasarides, PhD, David Sternberg, MD PhD

Blood (2019) 134 (Supplement_1): 3176.

https://doi.org/10.1182/blood-2019-126818

Published: 2019

Journal Articles

Comparison of Spleen Volumes Estimated Using Planimetry and Prolate Ellipsoid Methods on MRI in Myelofibrosis Patients

Alpana Harisinghani, MD MBBS, Manish Sharma, MD, Michael O'Connor, PhD, Ramanaidu Darapureddi, MSc, PGDPM, Sayali Karve, PhD, Sanjeev Pitla, MD, Shobitha Manikandan, Rohit Sood, MD PhD

Blood (2018) 132 (Supplement 1): 5472.

https://doi.org/10.1182/blood-2018-99-118402

Published: 2018

Journal Articles

Moderate Reduction in LVEF Is Associated with an Increased Risk of Post-HSCT Symptomatic Cardiomyopathy

Kinjal Parikh, MD, Lekha Mikkilineni, MD, Fern Martin, MD, Dolores Grosso, R.N., CRNP, DNP, Benjamin Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez Outschoorn, MD, Manish Sharma, MD, Mark Weiss, MD, John L. Wagner, MD, Neal Flomenberg, MD, Joanne Filicko-O'Hara, MD

Blood (2015) 126 (23): 2023.

https://doi.org/10.1182/blood.V126.23.2023.2023

Published: 2015

Journal Articles

Autologous Hematopoietic Cell Transplantation in Patients with High Risk Multiple Myeloma: Post- Transplant Responses Do Not Translate to Longer Survival

Manish Sharma, MD, Parmeswaran Hari, MD MRCP, MS, Jennifer Le-Rademacher, PhD, Amrita Krishnan, Yago Nieto, MD PhD, Cristina Gasparetto, MD, Jiaxing Huang, MS, Emma C. Scott, MD, Anita D'Souza, MBBS, MD

Blood (2015) 126 (23): 1979.

https://doi.org/10.1182/blood.V126.23.1979.1979

Published: 2015

Journal Articles

Detection of Acquired Uniparental Disomy (aUPD) with HLA Typing and Microarray Analysis after T Cell-Containing Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Dolores Grosso, DNP, Beth Colombe, PhD, Zi-Xuan Wang, PhD, Matthew Carabasi, MD, Onder Alpdogan, MD, Joanne E. Filicko-O'Hara, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Manish Sharma, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2015) 126 (23): 3165.

https://doi.org/10.1182/blood.V126.23.3165.3165

Published: 2015

Journal Articles

Creatinine > 1.5 Mg/Dl and MDS Diagnosis Predicts Poor Outcome Following HSCT

Fern Martin, MD, Lekha Mikkilineni, MD, Kinjal Parikh, MD, Dolores Grosso, DNP, Benjamin E Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Manish Sharma, MD, Mark Weiss, MD, John L. Wagner, MD, Neal Flomenberg, MD, Joanne Filicko-O'Hara, MD

Blood (2015) 126 (23): 3220.

https://doi.org/10.1182/blood.V126.23.3220.3220

Published: 2015

Journal Articles

Smoking History and Pre-Transplant Pulmonary Function Predict Post-Transplant Respiratory Failure, Acute Renal Failure Requiring Dialysis and 100-Day Mortality in Allogeneic Bone Marrow Transplantation

Lekha Mikkilineni, MD, Kinjal Parikh, MD, Fern Martin, MD, Dolores Grosso, R.N., CRNP, DNP, Benjamin Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Manish Sharma, MD, Mark Weiss, MD, John L. Wagner, MD, Neal Flomenberg, MD, Joanne E. Filicko-O'Hara, MD

Blood (2015) 126 (23): 4394.

https://doi.org/10.1182/blood.V126.23.4394.4394

Published: 2015

Journal Articles

CD3/8 T-Cell Responses to CMV Reactivation in Patients Undergoing Haploidentical Transplants: A Retrospective Analysis

Mahasweta Gooptu, MD, Benjamin Leiby, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez, MD, Barbara Pro, MD, Manish Sharma, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD, Dolores Grosso, DNP

Blood (2014) 124 (21): 1170.

https://doi.org/10.1182/blood.V124.21.1170.1170

Published: 2014

Journal Articles

Bortezomib With High-Dose Melphalan, Arsenic Trioxide, and Ascorbic Acid In a Preparative Regimen For Multiple Myeloma: 5-Year Follow Up

A. Megan Cornelison, MS, PA-C, Yvonne Dinh, Manish Sharma, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, MD, Chitra M. Hosing, MD, Uday R Popat, MD, Richard E Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2013) 122 (21): 5547.

https://doi.org/10.1182/blood.V122.21.5547.5547

Published: 2013

Journal Articles

Multiple Myeloma (MM) In Older (>70 year) Patients - Similar Benefit From Autologous Hematopoietic Cell Transplantation (AHCT) Compared With Younger Patients

Manish Sharma, MD, Mei-Jie Zhang, PhD, Xiaobo Zhong, MS, Cristina J. Gasparetto, MD, Amrita Y. Krishnan, MD, Sagar Lonial, M.D., Parameswaran Hari, MD, MS

Blood (2013) 122 (21): 416.

https://doi.org/10.1182/blood.V122.21.416.416

Published: 2013

Journal Articles

Confirmation of A Strong Relationship Between Race and Probability of Transplant Among Patients Referred for Hematopoietic Cell Transplantation (HCT) for Hematological Maliganancies – A 17 Year Experience

Manish Sharma, MD, Thomas R Klumpp, MD, John A Ulicny, MS, Omotayo O. Fasan, MBBS, Patricia Kropf, MD, Mary Ellen Martin, MD, Kenneth F. Mangan, MD

Blood (2012) 120 (21): 4266.

https://doi.org/10.1182/blood.V120.21.4266.4266

Published: 2012

Journal Articles

Improved Early Outcomes with T-Cell Replete (TCR) Compared with T-Cell Depleted (TCD) Haploidentical Stem Cell Transplantation (HaploSCT)

Stefan O Ciurea, MD, Rima M. Saliba, PhD, Ulas D. Bayraktar, MD, Susan Xie, Gabriela Rondon, MD, Simrit Parmar, M.D., Partow Kebriaei, MD, Nivia Montes, PA, Manish Sharma, MD, Marina Konopleva, M.D., Ph.D., Yago Nieto, MD, PhD, Muzaffar H. Qazilbash, MD, Amin M Alousi, MD, Borje S Andersson, MD, PhD, Chitra M Hosing, MD, Elizabeth J Shpall, MD, Issa F. Khouri, MD, Marcos de Lima, MD, Richard Champlin, MD

Blood (2011) 118 (21): 320.

https://doi.org/10.1182/blood.V118.21.320.320

Published: 2011

Journal Articles

Evaluating Trends in Diagnostic and Prognostic Testing for Multiple Myeloma

C. J. Fidler, Ahmed Kamel Abou Hussein, MD, Neel Gandhi, Vinit Karur, MD, Manish Sharma, MD, Thomas R Klumpp, MD, Patricia Kropf, MD, Mary Ellen Martin, MD, Robert V. Emmons, MD, Kenneth F. Mangan, MD

Blood (2011) 118 (21): 2067.

https://doi.org/10.1182/blood.V118.21.2067.2067

Published: 2011

Journal Articles

LACK of ASSOCIATION BETWEEN Race and Probability of TRANSPLANT AMONG PATIENTS Referred for Hematopoietic CELL TRANSPLANTATION (HCT) for MULTIPLE Myeloma

Manish Sharma, MD, Michael Bromberg, MD, PhD, Thomas R. Klumpp, MD, Patricia Kropf, MD, Mary Ellen Martin, MD, Robert V. Emmons, MD, Kenneth F. Mangan, MD

Blood (2011) 118 (21): 3129.

https://doi.org/10.1182/blood.V118.21.3129.3129

Published: 2011

Journal Articles

Poor FEV1 or DLco on Pre-Transplant PFT Does Not Compromise Outcomes In Patients Undergoing a Reduced-Intensity Allogeneic Progenitor Cell Transplant.

Manish Sharma, MD, Rima M. Saliba, PhD, Muzaffar H. Qazilbash, MD, Grace-Julia Okoroji, Uday Popat, MD, Marcos de Lima, MD, Richard Champlin, Chitra Hosing, MD

Blood (2010) 116 (21): 1322.

https://doi.org/10.1182/blood.V116.21.1322.1322

Published: 2010

Journal Articles

Outcome of IgD Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

Sofia Qureshi, MD, Manish Sharma, MD, Chitra Hosing, MD, Floralyn L Mendoza, MD, Jatin Shah, MD, Amin Alousi, MD, Paolo Anderlini, MD, Partow Kebriaei, MD, Issa F Khouri, MD, Uday Popat, MD, Marcos de Lima, MD, Richard E Champlin, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD

Blood (2009) 114 (22): 4354.

https://doi.org/10.1182/blood.V114.22.4354.4354

Published: 2009

NARROW

The Clinical Relevance of Residual, Persistent and Elongated Abnormal Sized Nodes By Longest Diameter (LDi) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL), Otherwise in a Complete Remission (CR)

Mantle Cell Lymphoma: Incidence of Gastrointestinal Involvement and Correlation with Overall Response- Retrospective Review of Multiple Multicenter Trials

REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Comparison of CT and PET-Based Assessments per Lugano Criteria in FDG-Avid Lymphoma- a Retrospective Analysis of Independent Review Assessments

Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Comparison of Spleen Volumes Estimated Using Planimetry and Prolate Ellipsoid Methods on MRI in Myelofibrosis Patients

Moderate Reduction in LVEF Is Associated with an Increased Risk of Post-HSCT Symptomatic Cardiomyopathy

Autologous Hematopoietic Cell Transplantation in Patients with High Risk Multiple Myeloma: Post- Transplant Responses Do Not Translate to Longer Survival

Detection of Acquired Uniparental Disomy (aUPD) with HLA Typing and Microarray Analysis after T Cell-Containing Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Creatinine > 1.5 Mg/Dl and MDS Diagnosis Predicts Poor Outcome Following HSCT

Smoking History and Pre-Transplant Pulmonary Function Predict Post-Transplant Respiratory Failure, Acute Renal Failure Requiring Dialysis and 100-Day Mortality in Allogeneic Bone Marrow Transplantation

CD3/8 T-Cell Responses to CMV Reactivation in Patients Undergoing Haploidentical Transplants: A Retrospective Analysis

Bortezomib With High-Dose Melphalan, Arsenic Trioxide, and Ascorbic Acid In a Preparative Regimen For Multiple Myeloma: 5-Year Follow Up

Multiple Myeloma (MM) In Older (>70 year) Patients - Similar Benefit From Autologous Hematopoietic Cell Transplantation (AHCT) Compared With Younger Patients

Confirmation of A Strong Relationship Between Race and Probability of Transplant Among Patients Referred for Hematopoietic Cell Transplantation (HCT) for Hematological Maliganancies – A 17 Year Experience

Improved Early Outcomes with T-Cell Replete (TCR) Compared with T-Cell Depleted (TCD) Haploidentical Stem Cell Transplantation (HaploSCT)

Evaluating Trends in Diagnostic and Prognostic Testing for Multiple Myeloma

LACK of ASSOCIATION BETWEEN Race and Probability of TRANSPLANT AMONG PATIENTS Referred for Hematopoietic CELL TRANSPLANTATION (HCT) for MULTIPLE Myeloma

Poor FEV1 or DLco on Pre-Transplant PFT Does Not Compromise Outcomes In Patients Undergoing a Reduced-Intensity Allogeneic Progenitor Cell Transplant.

Outcome of IgD Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only